semaglutide weight loss preston hollow for Loss: Clinical Evidence and Personaliza... – PlexusDx ✨ 1 year on GLP-1

At Balanced, peptide therapy is Phase 1 of most treatment plans

For FDA-approved GLP-1 medications, contraindications include a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, and a history of severe allergic reaction to the drug

As a glucagon-like peptide-1 (GLP-1) receptor agonist, semaglutide simulates the action of the endogenous hormone GLP-1, which plays a crucial role in glucose metabolism and appetite regulation

The new research published in April 2026 showed improved blood pressure and cholesterol markers in participants, but a dedicated cardiovascular outcomes trial with hard endpoints is still in progress

Svensson, J., Lall, S., Dickson, S